Latest Us Expansion News

Janus Electric has locked in two California HVIP vouchers worth US$112,500 each for its initial US vehicle conversions, validating its tech under a key decarbonisation program. It also inked a non-binding MOU with Energy One to explore battery swap and charging infrastructure for Class 8 freight trucks across North America.

PainChek has secured a landmark agreement with Sabra Health Care REIT to deploy its AI-powered pain assessment across up to 20,000 beds in North America, marking a pivotal step in its US expansion.

Galilee Energy has completed the Zydeco-1 well design and directional plan, achieving around US$100,000 in cost savings and advancing steadily toward a Q2 2026 drilling start. The project targets Gulf Coast natural gas and condensate markets, supported by a newly appointed US Advisory Board.

AML3D has successfully commissioned a large-scale ARCEMY X 6700 metal 3D printer at US defence supplier FasTech, completing a $1.7 million order and signalling a strategic expansion in the US industrial manufacturing market.

Cyclopharm Limited is rapidly expanding its Technegas® lung imaging technology across the US, securing new contracts and advancing clinical guideline recognition that could boost adoption.

Galilee Energy has appointed a US Advisory Board to drive its Gulf Coast oil and gas expansion, targeting low-risk brownfield assets. The company’s maiden Zydeco-1 well in Louisiana is set to spud in Q2 2026, marking a key milestone in its US growth strategy.

Ava Risk Group has announced a $7 million strategic investment from US-based Hale Capital to fuel its expansion into the US federal security market and accelerate product development. This partnership aims to position Ava as a global leader in critical infrastructure protection with a strong US presence.

4DMedical’s advanced lung imaging technology CT:VQ™ has been deployed at the Mayo Clinic, marking the sixth top US academic medical centre to adopt the system within seven months of FDA clearance.

Stakk Limited’s U.S. subsidiary has landed its largest-ever contract worth A$7.85 million, marking a significant step in expanding its AI-native trust infrastructure across regulated industries including healthcare.

Cyclopharm has secured a multi-site agreement with Northwestern Medicine, marking a major expansion into Chicago’s healthcare market and reinforcing its US growth strategy.

Ovanti Limited has secured $711,200 through a discounted share placement to professional investors, aiming to support its global operations and expansion into the US buy now, pay later market.

Cyclopharm has secured a significant multi-site agreement with the University of Pennsylvania Health System, marking a major step in its US expansion with installations across 11 clinical locations.